» Authors » Bowei Su

Bowei Su

Explore the profile of Bowei Su including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 77
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ewy S, Pham H, Quan K, Su B, Tachdjian R
J Drugs Dermatol . 2019 Sep; 18(9):947-949. PMID: 31524994
Bullous pemphigoid (BP) is a rare blistering skin disease that is commonly treated with corticosteroids and immunosuppressive agents. Here, we present a 74-year-old woman with severe BP following a leg...
2.
Koon H, Su B, Xu C, Mussatto C, Tran D, Lee E, et al.
Am J Physiol Gastrointest Liver Physiol . 2016 Aug; 311(4):G610-G623. PMID: 27514478
C. difficile infection (CDI) is a common debilitating nosocomial infection associated with high mortality. Several CDI outbreaks have been attributed to ribotypes 027, 017, and 078. Clinical and experimental evidence...
3.
Yoo J, Ho S, Tran D, Cheng M, Bakirtzi K, Kukota Y, et al.
Cell Mol Gastroenterol Hepatol . 2015 Mar; 1(1):55-74.e1. PMID: 25729764
Background And Aims: Cathelicidin (LL-37 in human and mCRAMP in mice) represents a family of endogenous antimicrobial peptides with anti-inflammatory effects. LL-37 also suppresses collagen synthesis, an important fibrotic response,...
4.
Cheng M, Ho S, Yoo J, Tran D, Bakirtzi K, Su B, et al.
Clin Exp Gastroenterol . 2015 Jan; 8:13-29. PMID: 25565877
Background: Cathelicidin (LL-37 in humans and mCRAMP in mice) represents a family of endogenous antimicrobial and anti-inflammatory peptides. Cancer-associated fibroblasts can promote the proliferation of colon cancer cells and growth...